Ardelyx, Inc. ARDX
Key Stats
- Today's Range
- $3.90 – $4.12
- 50-Day Range
- $3.90 – $6.47
- 52-Week Range
- $3.90 – $8.40
- Volume
- 10.81 million shs
- Average Volume
- 4.18 million shs
- Market Cap
- $996.75 million
- P/E Ratio
- —
- Dividend Yield
- —
Valuation
- P/E Ratio
- —
- Price / Book
- 6.69
- Price / Sales
- 2.21
Short Interest
- Short Interest
- 0.76%
- Days to Cover
- 5.65
Financials (TTM)
- Revenue
- $450.89 million
- Net Income
- $-55,702,000
- Net Margin
- -12.35%
- Return on Equity
- -37.38%
- Debt-to-Equity
- 1.69
About Ardelyx, Inc.
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.
Related Stocks
Compare head-to-head: ARDX vs LLY·ARDX vs JNJ·ARDX vs ABBV·ARDX vs ABT
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.